Key result
Intracoronary tissue-type plasminogen activator (t-PA) was employed successfully in four patients referred for emergency cardiac catheterization during evolving myocardial infarction.
Case Report (n=4)
Intracoronary t-PA was successfully used in four patients during evolving myocardial infarction, highlighting its potential role in emergency cardiac catheterization.
May support feasibility in evolving MI; leaves open efficacy and safety pending controlled trials.
Intracoronary tissue-type plasminogen activator (t-PA) was employed successfully before, after, or in place of coronary artery angioplasty in four patients referred for emergency cardiac catheterization during evolving myocardial infarction. The potential roles of intracoronary thrombolysis, dose considerations for intracoronary t-PA, factors influencing the choice of plasminogen activator, and safety issues are discussed.
No takes yet. Share an insight, caveat, or question.
Alan J. Tiefenbrunn (1990) conducted a case report in Evolving myocardial infarction (n=4). Intracoronary tissue-type plasminogen activator (t-PA) was evaluated. Intracoronary tissue-type plasminogen activator (t-PA) was employed successfully in four patients referred for emergency cardiac catheterization during evolving myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: